← Back to IBO

Impact BioMedical, Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 07/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 07/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 14/05/2025
$0$0$0$0
−$0.7−$2.3−$1.5−$14−$1.3$4.2−$0.9−$1
−$0.01−$0.02−$0.12−$1.18−$0.11$0.06−$0.09−$0.10
108108121212121010

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.